Results 1 to 10 of about 24,231 (256)

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS [PDF]

open access: yesFrontiers in Cardiovascular Medicine
PurposeTo identify the most commonly reported drugs associated with QT interval prolongation in the FDA Adverse Event Reporting System (FAERS) and evaluate their risk for QT interval prolongation.MethodsWe employed the preferred term (PT ...
Haowen Tan   +9 more
doaj   +2 more sources

Association Between Disturbed Serum Phosphorus Levels and QT Interval Prolongation [PDF]

open access: yesKidney International Reports
Introduction: QT interval prolongation is a risk factor for fatal arrhythmias and other cardiovascular complications. QT interval prolongation in patients on hemodialysis (HD) is not well understood.
Sho Sasaki   +6 more
doaj   +2 more sources

Prevalence of the QT interval prolongation and its risk factors in hospitalized geriatric patients: findings of a single center cross-sectional study in Pakistan [PDF]

open access: yesBMC Geriatrics
Background and objectives Geriatric inpatients are particularly susceptible to Torsades de Pointes (TdP) because they are usually polymorbid and often take QT-prolonging drugs.
Huma Tanveer   +9 more
doaj   +2 more sources

A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin [PDF]

open access: yesJournal of Pharmaceutical Health Care and Sciences
Background As methadone can prevent the development of opioid resistance, it has application in alleviating cancer-related pain that proves challenging to manage with other opioids. QT interval prolongation is a serious side effect of methadone treatment,
Ryusuke Ouchi   +9 more
doaj   +2 more sources

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval

open access: yesFrontiers in Pharmacology, 2023
Introduction: Acquired QT interval prolongations due to drug side effects can result in detrimental arrhythmia. Maternal use of placenta-permeable drugs may lead to fetal exposure, thus leading to an increased risk of neonatal QT prolongation and ...
Holger Michel   +13 more
doaj   +4 more sources

Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction. [PDF]

open access: yesPLoS ONE
Heart failure (HF) with reduced ejection fraction (HFrEF) is a risk factor for drug-induced QT interval prolongation. It is unknown if HF with preserved ejection fraction (HFpEF) is also associated with an increased risk.
Chien-Yu Huang   +5 more
doaj   +2 more sources

Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones

open access: yesJournal of the Formosan Medical Association, 2023
Background: Fluoroquinolones, crucial components of treatment regimens for drug-resistant tuberculosis (TB), are associated with QT interval prolongation and risks of fatal cardiac arrhythmias. However, few studies have explored dynamic changes in the QT
Ke-Shiuan Ju   +8 more
doaj   +1 more source

Bedaquiline Correlation to QT Interval Prolongation in DR-TB Patients

open access: yesJurnal Respirasi, 2022
Introduction: The regimen of drug-resistant tuberculosis (DR-TB) is Bedaquiline. One of the adverse events is QT interval prolongation, which can increase the risk of Torsade de Pointes (TdP) and lead to death. DR-TB patient screening before starting the
Vandu Primadana   +2 more
doaj   +1 more source

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Interval QT prolongation is a predictor of the life-threatening cardiac arrhythmias — polymorphic ventricular tachycardia (torsade de pointes). Long QT syndrome may be congenital or acquired.
N. V. Furman, S. S. Shmatova
doaj   +3 more sources

Prolongation of the QT interval by ketanserin [PDF]

open access: yesPostgraduate Medical Journal, 1988
Summary In hypertensive patients single doses of ketanserin 40 mg prolonged the corrected QT interval (QTc) for at least 8 hours, with a maximal increase of 35 ms (P less than 0.001, n = 6) after 2 hours. During chronic dosing (20 and 40 mg b.d.) the QTc was further prolonged, by 46 and 45 ms respectively.
H A, Cameron, P C, Waller, L E, Ramsay
openaire   +2 more sources

Home - About - Disclaimer - Privacy